Drug/device borderline: new guidance after 8 years
This article was originally published in Clinica
Executive Summary
The European Commission has published an updated guidance document on borderline products, namely drug-delivery products and medical devices which incorporate as an integral part, an ancillary substance or ancillary human blood derivative.